compounded semaglutide deaths Recent reports link around 10 and 100 hospitalizations in the U.S. to versions of semaglutide, sold under the brand name Ozempic by Novo Nordisk. The company has raised concerns with Novo Nordisk CEO Warns of

Survodutide , another GLP-1/glucagon dual agonist from Boehringer Ingelheim, is advancing through clinical trials

The popularity of GLP-1 agonists to treat obesity has been skyrocketing in recent months, leading to both shortages and price increases

1 Together, these actions help maintain a stable blood sugar level, particularly after meals

Clinical trials indicate that retatrutide can result in up to 24% weight loss from baseline weight, a significant transformation

Patients with a diagnosis of active IIH were identified and recruited from a single tertiary referral hospital (University Hospitals Birmingham NHS Foundation Trust)

Side effects vary by peptide: These may include fatigue, water retention, appetite changes, or tingling